News Releases

08/06/2009 US Oncology Reports Second Quarter Operating Results HOUSTON, TX, August 6, 2009 – US Oncology, Inc. (“US Oncology” or “the Company”), one of the nation’s largest cancer care services companies, reported revenue of $881.6 million, EBITDA of $39.9 million, Adjusted EBITDA of $62.7 million, net loss of $7.6 million and operating cash flow of $42.5 million for the three months ended June 30, 2009. View entire press release.